HS-104, a PI3K inhibitor, enhances the anticancer efficacy of gemcitabine in pancreatic cancer

Kyung Hee Jung(Inha University), Soon‐Sun Hong(Korea Advanced Institute of Science and Technology)
International Journal of Oncology
May 9, 2014
Cited by 14


Related Papers